Both Semaglutide and this treatment represent groundbreaking strategies to treating type 2 diabetes, and increasingly, obesity. Tirzepatide is a twin receptor activator that targets several receptors involved in blood sugar control: this peptide and another incretin. Mounjaro, often seen as a bra… Read More